Symptoms and signs

Author Susan B. Haynes' new book "The Terror Zone" is a gripping thriller about a woman spiraling through a world of pain, revulsion, and seething psychosis

Retrieved on: 
Wednesday, May 26, 2021
Branches of biology, Nervous system, Symptoms and signs, Psychopathology, Psychosis, Torment, Pain

She has two published books under her belt, and several poems published through the International Library of Poetry.

Key Points: 
  • She has two published books under her belt, and several poems published through the International Library of Poetry.
  • Published by Page Publishing, Haynes' new book begins with a stranger crying out in the night.
  • Haynes writes, "Terrified of what invasive torment the assailant might inflict on her next, she spirals through a world of pain, revulsion, and seething psychosis.
  • As her mind spins a web of deceit and deception, she literally opens the doorway to the terror zone."

Utah PTA Passes Historic Resolution Bringing Migraine and Headache Disease Education into the Classroom

Retrieved on: 
Tuesday, May 18, 2021
Migraine, Medicine, Symptoms and signs, Branches of biology, Headaches, Neurological disorders, Pain management, Headache, Cluster headache

b'SANTA MONICA, Calif., May 18, 2021 /PRNewswire/ --The Utah PTA recently passed an important resolution to bring migraine and headache education into the classroom statewide, while also providing much needed resources for students, parents, administrators, educators, and nurses.

Key Points: 
  • b'SANTA MONICA, Calif., May 18, 2021 /PRNewswire/ --The Utah PTA recently passed an important resolution to bring migraine and headache education into the classroom statewide, while also providing much needed resources for students, parents, administrators, educators, and nurses.
  • There are over 40 million people in the United States with migraine disease, and just overhalf have been diagnosed.
  • Also, there are 400,000 people with cluster headache, recognized as the most painful disease a person can have.
  • The campaign includesa powerful video, Growing up with Migraine , that showcaseswhy CHAMP\'s Migraine at School program is so important for migraine education through stories shared by kids and adults sharing what it is like to grow up with migraine disease.

Young Women with Chest Pain Wait Longer and Receive Less Urgent Care Than Men

Retrieved on: 
Saturday, May 15, 2021
Branches of biology, Symptoms and signs, Anatomy, Chest pain, Pain, Torso, Heartburn, Lightheadedness, Thorax, Shortness of breath, Indigestion

"\nThe study found young women were equally likely to arrive to the emergency department by ambulance as men.

Key Points: 
  • "\nThe study found young women were equally likely to arrive to the emergency department by ambulance as men.
  • Women in the study waited and average of 45 minutes to be evaluated by a provider while men were seen on average within 37 minutes.
  • These symptoms can include pain, pressure, or tightness in the chest, shortness of breath, nausea, indigestion, heartburn, sweating, lightheadedness, and fatigue.
  • "\nThe researchers were not able to determine why women with chest pain were treated differently than men.

The new MyoVision SERIES-5 DynaROM changes lives one patient at a time.

Retrieved on: 
Friday, May 14, 2021
Branches of biology, Nervous system, Symptoms and signs, Biomechanics, Nociception, Acute pain, Pain, Suffering, Soft tissue, Sports injury, Muscle

The DynaROM simultaneously measures range of motion and the muscle response during motion giving it the ability to document muscle guarding (the body\'s natural response to pain).

Key Points: 
  • The DynaROM simultaneously measures range of motion and the muscle response during motion giving it the ability to document muscle guarding (the body\'s natural response to pain).
  • So the handyman\'s doctor ordered a DynaROM test and what happened next made history.
  • The jury awarded $958K; one of the largest soft tissue injury awards in history.\nThe handyman described the DynaROM as, "The missing puzzle piece that validated my pain.
  • MyoVision has been manufacturing medical equipment in the US for the past 30 years.

Nationwide Survey by Averitas Reveals Painful Realities of Living with Diabetic Nerve Pain

Retrieved on: 
Friday, May 14, 2021
Health, Diabetes, Other Health, Managed care, Pharmaceutical, Biotechnology, Nervous system, Branches of biology, Symptoms and signs, Pain, Acute pain, Nociception, Neuropathic pain, Peripheral neuropathy, Caregiver

Overall, respondents have indicated they need to rest more often and reduce physical activity as a result of their pain.

Key Points: 
  • Overall, respondents have indicated they need to rest more often and reduce physical activity as a result of their pain.
  • Two thirds of the survey respondents reported needing a caregiver, and of those, 43% mentioned their spouse as their primary caregiver.
  • \xe2\x80\x9cThe U.S. represents a significant portion of the world\xe2\x80\x99s neuropathic pain patient population statistic and is expected to grow over the next decade.
  • Pain Severity in Diabetic Peripheral Neuropathy is Associated with Patient Functioning, Symptom Levels of Anxiety and Depression, and Sleep.

Ascendis Pharma A/S Announces Expansion of Global Clinical Reach for TransCon™ PTH with Filing of the Clinical Trial Notification for Phase 3 Clinical Trial in Adults with Hypoparathyroidism in Japan

Retrieved on: 
Wednesday, May 12, 2021
Symptoms and signs, Branches of biology, Medicine, XC2, Hallucinations, Paresthesia, Tetany, Forward-looking statement, Hypoesthesia, Headache, Pharma

In the short term, symptoms include weakness, severe muscle cramps (tetany), abnormal sensations such as tingling, burning and numbness (paresthesia), memory loss, impaired judgment and headache.

Key Points: 
  • In the short term, symptoms include weakness, severe muscle cramps (tetany), abnormal sensations such as tingling, burning and numbness (paresthesia), memory loss, impaired judgment and headache.
  • Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements.
  • Securities and Exchange Commission\xc2\xa0(SEC)\xc2\xa0on\xc2\xa0March 10, 2021 and Ascendis\xe2\x80\x99 other future reports filed with, or submitted to, the SEC.
  • Ascendis does not assume any obligation to update any forward-looking statements, except as required by law.\nAscendis,\xc2\xa0Ascendis Pharma, the\xc2\xa0Ascendis Pharma\xc2\xa0logo, the company logo and TransCon are trademarks owned by the\xc2\xa0Ascendis Pharma Group.

MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics

Retrieved on: 
Wednesday, May 5, 2021
Branches of biology, Pain, Acute pain, Symptoms and signs, Hallucinations, Counterculture of the 1960s, Entheogens, Lysergic acid diethylamide, Psychedelic drug, Master of Medicine, Pain management

b'NEW YORK, May 5, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company") (NASDAQ: MNMD) (NEO: MMED), (DE: MMQ), a leading psychedelic-inspired medicine company announces the launch of its Project Angie to advance the development of psychedelics, including LSD, to treat pain conditions.

Key Points: 
  • b'NEW YORK, May 5, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company") (NASDAQ: MNMD) (NEO: MMED), (DE: MMQ), a leading psychedelic-inspired medicine company announces the launch of its Project Angie to advance the development of psychedelics, including LSD, to treat pain conditions.
  • MindMed is currently exploring two primary clinical indications for the treatment of pain.\nFor the commencement of Project Angie, MindMed will initiate a study of LSD in a severe pain indication.
  • MindMed is currently preparing a pre-IND briefing package for this Phase 2a Proof of Concept study which it plans to submit to the FDA in the second half of 2021.
  • The exact mechanisms by which psychedelics may carry out their analgesic effect have not been fully characterized but may involve direct effects on endogenous pain modulation pathways.

Dr. Binod P. Shah, MD is recognized by Continental Who's Who

Retrieved on: 
Friday, April 30, 2021
Nervous system, Branches of biology, Symptoms and signs, WOODCLIFF LAKE, Rehabilitation, Pain

b"WOODCLIFF LAKE, N.J., April 30, 2021 /PRNewswire/ --Dr. Binod P. Shah, MD, is being recognized by Continental Who's Who as a Top Doctor for his professional excellence in the field of Spinal Pain Rehab and Medicine.

Key Points: 
  • b"WOODCLIFF LAKE, N.J., April 30, 2021 /PRNewswire/ --Dr. Binod P. Shah, MD, is being recognized by Continental Who's Who as a Top Doctor for his professional excellence in the field of Spinal Pain Rehab and Medicine.
  • This recognition also acknowledges his commitment to Spinal Pain Rehab and Medicine PC.
  • He proudly serves his patients with Spinal Pain Rehab and Medicine PC in Yonkers, New York, and Regenerative Medicine and Stem Cell Therapy INC. in Woodcliff Lake, NJ.
  • Shah's distinguished career began after he earned his medical degree at the Post Graduate Institute of Medical Education & Research.

Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Retrieved on: 
Monday, April 26, 2021
Alternative medicine, Mental health, Health, General Health, Pharmaceutical, Biotechnology, Hallucinations, Entheogens, Psychoactive drugs, Psychedelic drug, Psychoactive fungi, Hallucinogen, Psilocybin, Branches of biology, Symptoms and signs

The severity of AUD\xe2\x80\x94mild, moderate, or severe\xe2\x80\x94is based on the number of criteria met.1\n"The evidence of increased alcohol use during this ongoing pandemic is startling.

Key Points: 
  • The severity of AUD\xe2\x80\x94mild, moderate, or severe\xe2\x80\x94is based on the number of criteria met.1\n"The evidence of increased alcohol use during this ongoing pandemic is startling.
  • For so many individuals and families, Alcohol Use Disorder can be disruptive, even devastating.
  • There is no assurance that the use of psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition.
  • Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

StimaWELL North America Inc. Enters the US Market With Its State-of-the-art, Back-pain Relief, E Stim Therapy + Tens Device Called the StimaWELL 120MTRS; a Game-changer for Neck + Back Pain Recovery.

Retrieved on: 
Thursday, April 22, 2021
Technology, Health, Hardware, Medical devices, Branches of biology, Nervous system, Acute pain, Symptoms and signs, Pain, Pain management, Palliative care, Erotic electrostimulation, Back pain, Reinforcement

Since 80% of North American\xe2\x80\x99s experience neck + back pain1, the e-stim (EMS) market is experiencing exponential growth.

Key Points: 
  • Since 80% of North American\xe2\x80\x99s experience neck + back pain1, the e-stim (EMS) market is experiencing exponential growth.
  • StimaWELL North America Inc. is excited to deliver its superior quality, German manufactured products across the US.
  • This means that you can target any muscle in the back for reinforcement or pain relief.
  • I truly feel this is a game-changer for neck + pain relief and will help individuals and athletes recover faster and take their game to the next level.\xe2\x80\x9d\n'